Assisted oocyte activation following ICSI fertilization failure

Reprod Biomed Online. 2014 May;28(5):560-71. doi: 10.1016/j.rbmo.2014.01.008. Epub 2014 Jan 31.

Abstract

The capacity of intracytoplasmic sperm injection (ICSI) to permit almost any type of spermatozoa to fertilize oocytes has made it the most successful treatment for male factor infertility. Despite its high success rates, fertilization failure following ICSI still occurs in 1-3% of couples. Assisted oocyte activation (AOA) is being increasingly applied in human assisted reproduction to restore fertilization and pregnancy rates in couples with a history of ICSI fertilization failure. However, controversy still exists mainly because the artificial activating agents do not mimic precisely the initial physiological processes of mammalian oocyte activation, which has led to safety concerns. This review addresses the mechanism of human oocyte activation and the relatively rare phenomenon of fertilization failure after ICSI. Next, it describes the current diagnostic approaches and focuses on the application, efficiency and safety of AOA in human assisted reproduction.

Keywords: ICSI; assisted oocyte activation; diagnosis; failed fertilization; male infertility; safety.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Calcium / metabolism
  • Female
  • Fertilization in Vitro / adverse effects
  • Fertilization in Vitro / methods*
  • Humans
  • Infertility, Male / therapy
  • Male
  • Oocytes / cytology*
  • Oocytes / physiology*
  • Pregnancy
  • Semen Analysis
  • Sperm Injections, Intracytoplasmic* / adverse effects
  • Sperm-Ovum Interactions
  • Treatment Failure

Substances

  • Calcium